Information Provided By:
Fly News Breaks for September 26, 2016
BABY
Sep 26, 2016 | 08:19 EDT
Roth Capital analyst Chris Lewis notes that Natus Medical announced the acquisition of Otometrics for $145M and an expected Q3 revenue shortfall. While the analyst is disappointed with the shortfall, he believes the main driver is transient in nature and should pass by the beginning of 2017. Further, Lewis sees the Otometrics acquisition as a "meaningful positive" for Natus Medical as it significantly expands the company and should allow it to reach $500M in annual revenues in 2017. He reiterates a Buy rating and $47 price target on the shares.
News For BABY From the Last 2 Days
There are no results for your query BABY